Evidence map›Paper›PMID 24835245›Full record

ArticlePloS one2014

The role of the HIF-1α transcription factor in increased cell division at physiological oxygen tensions.

Samantha Carrera, Joana Senra, Maria Isabel Acosta, Mohammad Althubiti, Ester M Hammond, Petra J de Verdier, Salvador Macip

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 32 citations in OpenAlex.

  1. Enhancing the efficacy of VEGF inhibitors by co-inhibition of HIF in the treatment of glioblastoma.Apoptosis : an international journal on programmed cell death · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. In Vitro Angiogenesis Inhibition and Endothelial Cell Growth and Morphology.International journal of molecular sciences · 2022
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Endothelial HIF-2α contributes to severe pulmonary hypertension due to endothelial-to-mesenchymal transition.American journal of physiology. Lung cellular and molecular physiology · 2018
    Article
  12. Article
  13. Article
  14. Modeling tumor cell adaptations to hypoxia in multicellular tumor spheroids.Journal of experimental & clinical cancer research : CR · 2017
    Review
  15. Review
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Samantha CarreraDepartment of Biochemistry, University of Leicester, Leicester, United Kingdom.
Joana SenraCancer Research U.K./MRC Gray Institute for Radiation Oncology and Biology, Department of Oncology, University of Oxford, Oxford, United Kingdom.
Maria Isabel AcostaDepartment of Biochemistry, University of Leicester, Leicester, United Kingdom.
Mohammad AlthubitiDepartment of Biochemistry, University of Leicester, Leicester, United Kingdom.
Ester M HammondCancer Research U.K./MRC Gray Institute for Radiation Oncology and Biology, Department of Oncology, University of Oxford, Oxford, United Kingdom.
Petra J de VerdierKarolinska Institutet, Department of Molecular Medicine and Surgery, Urology Laboratory, and Department of Urology, Karolinska University Hospital, Stockholm, Sweden.
Salvador MacipDepartment of Biochemistry, University of Leicester, Leicester, United Kingdom.
University of Leicester · GBCancer Research UK · GBKarolinska Institutet · SEUniversity of Oxford · GB

Funding

Cancer Research UK 19276Medical Research Council
6 · The paper itself

Abstract

HIF-1 is a transcription factor that mediates the cellular responses to low oxygen environments, mainly as a result of having an oxygen-labile subunit, HIF-1α. HIF-1α has been carefully studied in the context of severe hypoxic stresses (<1% O2), but it is also known to be present at oxygen tensions commonly found in normal tissues in vivo (∼1-13% O2), albeit at much lower levels. Its role under these physiological conditions is not fully understood. Here, we show that a transcriptionally active HIF-1α was up-regulated at 5% O2, both in normal and cancer cells, but only some of its target genes were elevated as a result. HIF-1α induction was in part dependent on the activation of the ERK1/2 MAPK signalling pathway, which we have previously shown is active at 5% O2. We also found that HIF-1α does not contribute to the protection against DNA damage that can be observed in low oxygen environments, and that there are certain DNA damaging agents, such as doxorubicin and actinomycin D, that prevent HIF-1α induction independently of p53. Moreover, absence of HIF-1α significantly reduced the growth advantage of cells cultured at 5% O2. In view of these data, we conclude that HIF-1α can be induced and activated at physiological oxygen tensions in a MAPK-dependent manner and that, although this does not lead to pro-survival responses to stress, it determines the increased cell proliferation rates that are common under these conditions.

Indexed as

Cell ProliferationOxidative StressDactinomycinDNA DamageDoxorubicinHCT116 CellsHumansHypoxia-Inducible Factor 1, alpha SubunitMAP Kinase Signaling SystemMCF-7 CellsOxygenTumor Suppressor Protein p53Up-RegulationDactinomycinDoxorubicinHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitOxygenTumor Suppressor Protein p53

Identifiers

PMID24835245
PMCPMC4024011
OpenAlexW1994451593

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.